Thai Pharma Turns Snails and Orchids Into Skin Care

Thailand's oldest pharmacy is proving that the fountain of youth might be hiding in snails and orchids all along.

B.GRIMM Pharma, a company with roots dating back to 1878, has partnered with Chulalongkorn University to create a new line of skincare products based on Thai biodiversity. The collaboration transforms local ingredients like snail mucus extract and orchid compounds into treatments designed for what scientists call "skin longevity," building healthy skin that lasts rather than just masking wrinkles.

The timing couldn't be better. Thailand's skincare market is growing 5 to 7 percent annually as people shift from treating problems to preventing them. The company's new EXXE' brand focuses on balancing the skin microbiome, the community of helpful bacteria that acts as a natural shield against pollution and environmental damage.

Professor Anchalee Tassanakajon from Chulalongkorn University leads the research team developing these formulas. The partnership follows a public-private model that takes discoveries from the laboratory straight to consumers, ensuring the science actually works in real-world conditions.

Caroline Link, co-chair of B.GRIMM Pharma, explains that the approach represents a major shift for the company. Founded by German pharmacist Bernhard GRIMM and Austrian partner Erwin Müller, the business started as Siam Dispensary, the first Western-style pharmacy in Thailand. For over a century, they focused on importing medicines to fill gaps in local availability.

Now they're creating innovations that work specifically for tropical skin. The products avoid the typical anti-aging playbook in favor of strengthening skin structure from within, targeting two groups: PRO-AGE for preventing early aging signs, and PRO-AGE+ for deeper restoration.

The research model also tackles a bigger economic issue. By developing high-quality extracts from Thailand's own biodiversity, the company reduces the country's dependence on imported active ingredients. This creates economic value while supporting local ecosystems and research institutions.

The Ripple Effect

The partnership between B.GRIMM Pharma and Chulalongkorn University shows how scientific collaboration can unlock hidden value in natural resources. By studying Thailand's unique plants and organisms through a rigorous scientific lens, researchers are discovering compounds that outperform synthetic alternatives. The approach has inspired other Thai companies to look closer at their own backyard for innovation.

The model proves that businesses can grow while giving back to the communities they serve. B.GRIMM Pharma maintains its century-old mission of making healthcare accessible, with 90 percent of its portfolio focused on affordable generic medicines across major disease areas. The consumer health division, including the new skincare lines, accounts for just 10 percent but represents the company's investment in preventive care.

As healthcare worldwide shifts from treating illness to maintaining wellness, Thailand's biodiversity is becoming a blueprint for sustainable innovation that benefits both people and the planet.